Antiarrhythmic effects of ranolazine in canine pulmonary vein sleeve preparations.
about
Electrophysiologic and antiarrhythmic effects of AZD1305 in canine pulmonary vein sleevesRanolazine in Cardiac ArrhythmiaRegulation of intracellular Na(+) in health and disease: pathophysiological mechanisms and implications for treatmentMechanisms of ranolazine's dual protection against atrial and ventricular fibrillationNew treatment options for late Na current, arrhythmias, and diastolic dysfunctionSuppression of re-entrant and multifocal ventricular fibrillation by the late sodium current blocker ranolazineVoltage-Gated Sodium Channel Phosphorylation at Ser571 Regulates Late Current, Arrhythmia, and Cardiac Function In Vivo.Synergistic electrophysiologic and antiarrhythmic effects of the combination of ranolazine and chronic amiodarone in canine atriaSynergistic effect of the combination of ranolazine and dronedarone to suppress atrial fibrillation.Emerging clinical role of ranolazine in the management of angina.Ranolazine: a new approach to treating an old problem.Antiarrhythmic effects of simvastatin in canine pulmonary vein sleeve preparationsAntiarrhythmic effects of losartan and enalapril in canine pulmonary vein sleeve preparations.Electrophysiologic basis for the antiarrhythmic actions of ranolazine.Comparison of electrophysiological and antiarrhythmic effects of vernakalant, ranolazine, and sotalol in canine pulmonary vein sleeve preparations.Electrophysiological characteristics of canine superior vena cava sleeve preparations: effect of ranolazine.Rate-dependent effects of vernakalant in the isolated non-remodeled canine left atria are primarily due to block of the sodium channel: comparison with ranolazine and dl-sotalolRanolazine inhibits voltage-gated mechanosensitive sodium channels in human colon circular smooth muscle cells.Ranolazine versus amiodarone for prevention of postoperative atrial fibrillation.Role of late sodium channel current block in the management of atrial fibrillation.The Effects of Ranolazine on Paroxysmal Atrial Fibrillation in Patients with Coronary Artery Disease: A Preliminary Observational Study.Potent antiarrhythmic effects of chronic amiodarone in canine pulmonary vein sleeve preparationsAntiarrhythmic effects of the highly selective late sodium channel current blocker GS-458967The Use of Ranolazine in the Management of Recurrent Atrial Fibrillation After Percutaneous Radiofrequency AblationFibroblast growth factor 23 dysregulates late sodium current and calcium homeostasis with enhanced arrhythmogenesis in pulmonary vein cardiomyocytes.New developments in atrial antiarrhythmic drug therapy.Drug-induced QT-interval prolongation: considerations for clinicians.The pharmaceutical pipeline for atrial fibrillation.Mechanisms of termination and prevention of atrial fibrillation by drug therapy.Ranolazine: an antianginal drug with antiarrhythmic properties.A focus on antiarrhythmic properties of ranolazine.Ranolazine: a review of its use as add-on therapy in patients with chronic stable angina pectoris.Pulmonary Vein Sleeves as a Pharmacologic Model for the Study of Atrial Fibrillation.Ranolazine as a promising treatment option for atrial fibrillation: electrophysiologic mechanisms, experimental evidence, and clinical implications.Combined actions of ivabradine and ranolazine reduce ventricular rate during atrial fibrillation.Enhanced Late Na and Ca Currents as Effective Antiarrhythmic Drug Targets.Ranolazine inhibits shear sensitivity of endogenous Na+ current and spontaneous action potentials in HL-1 cells.Antiarrhythmic properties of ranolazine--from bench to bedside.Atrial-selective inhibition of sodium-channel current by Wenxin Keli is effective in suppressing atrial fibrillation.Ranolazine selectively blocks persistent current evoked by epilepsy-associated Naν1.1 mutations.
P2860
Q24601144-681AD3D8-04FB-4D70-8AD1-5C8DDA637823Q26784029-BB1447C8-7723-4C08-B99D-A8EFDD44E1C2Q26863221-D8774786-9DA8-4D0A-8254-B3FC9A6FB39CQ26995558-58F37978-F687-4CD4-942E-4851785912C6Q27012532-D54DEA5D-C23E-491D-AF7C-CAB76E5A0F9EQ30622882-F6CDEA38-651C-4D0C-AEA3-8A67A3846867Q30973910-79DFF9CE-EEF6-4B6E-84D4-64FECBD5F8E6Q33665436-9109736A-C494-49DB-B4B1-1EC0E183F50DQ34181734-F850DDA7-15BB-49FA-8B2B-8E69C12ED03FQ34235939-2C40124E-94FE-48D3-9609-1B801F13A79AQ34457675-41EFC891-DD53-400C-BAB5-D126C926AA53Q34682939-549B00B3-C1B2-44CD-A594-16A92F63A114Q34700436-D7DE1616-5B0A-4CB3-BFC8-8F17F6BE7D33Q35091243-0CDD0D9F-FA7E-4002-9E6D-99F27EE5594FQ35785780-5D6FA850-E238-4B63-ACFE-824AAB38B526Q35897540-625F3A3B-2DCE-46F8-85BC-2035C3B5F669Q35897567-4FB843D6-8DD5-4E6F-BC61-F9B2D554463DQ36066445-9EAF2924-A8EB-4853-B2FB-E0AD2CF8C297Q36534150-F9DE153E-49CE-419C-BE30-6E8E4709236EQ36570112-C26D0F73-4EC5-4509-B859-F4BFFEC85DF6Q37115123-68F204EA-158C-4CBF-8956-202950E08322Q37315220-00DEC025-8B8A-494F-9C63-69E9F0281C86Q37333069-5FC03274-B981-4267-89C3-9BBF310663FCQ37496011-8F8A0613-B31C-4856-A5F5-48DAC77C2CB4Q37688345-14CA8E58-82C9-4FE3-B72C-6527AACDC248Q37697498-52D416A4-517D-4EC4-85DC-F4767CC71E67Q37767425-67FBF1ED-0D5F-480C-8DCB-0D7C7A49ED31Q37821928-EDF9D0CD-64CF-4AF2-A9C6-DFAD004C6E12Q37844891-E82F4992-C61B-4EE1-BF06-3CF1FF2EA3BAQ37910205-811D72FE-B08A-4136-8FE6-F36401D06C4CQ38001669-8BDA24C4-6B22-4219-99A7-7E2A90D8F45CQ38074900-9FF7402E-625C-4B46-8BDB-F985844C79C0Q38226807-1D6711BC-ACA1-4243-BF1B-F6AF9F12AF67Q38241316-21A950E5-5686-4F97-9352-25409D05394DQ38547436-F8948C94-3E3D-44DB-A7BD-E8ED5F1815AEQ39144763-9087E132-D20A-445A-8182-1241EB23AF70Q39270116-7D3A3F85-7CD6-43ED-8BCD-4F305677E232Q39564664-AF781C9D-9DC5-4F2A-8959-3314E4AD5B05Q39760319-69A8E931-FE4E-4C37-886C-67B8B2FA8A69Q41121995-49A4A3C5-74DA-42EF-B7A1-C32C90DCD424
P2860
Antiarrhythmic effects of ranolazine in canine pulmonary vein sleeve preparations.
description
2008 nî lūn-bûn
@nan
2008年の論文
@ja
2008年論文
@yue
2008年論文
@zh-hant
2008年論文
@zh-hk
2008年論文
@zh-mo
2008年論文
@zh-tw
2008年论文
@wuu
2008年论文
@zh
2008年论文
@zh-cn
name
Antiarrhythmic effects of ranolazine in canine pulmonary vein sleeve preparations.
@en
type
label
Antiarrhythmic effects of ranolazine in canine pulmonary vein sleeve preparations.
@en
prefLabel
Antiarrhythmic effects of ranolazine in canine pulmonary vein sleeve preparations.
@en
P2093
P2860
P1433
P1476
Antiarrhythmic effects of ranolazine in canine pulmonary vein sleeve preparations
@en
P2093
Aaron Glass
Luiz Belardinelli
Serge Sicouri
P2860
P304
P356
10.1016/J.HRTHM.2008.03.018
P577
2008-03-21T00:00:00Z